Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Horvath

Showing results (71-80 of 164) with videos related to

Pageof 17
Sort By:
The Journal of Peptide Research : Official Journal of the American Peptide Society|July 1, 1997
Synthesis and biological properties of beta-MePhe3 analogues of deltorphin I and dermenkephalin: influence of biased chi 1 Phe3 residues on peptide recognition for delta-opioid receptorsA Misicka, S Cavagnero, R Horvath, et al.
Journal of Hypertension|April 7, 2021
ReplyKaty Bell, Jenny Doust, Kevin McGeechan, et al.
Life Sciences|January 1, 1997
Structure-activity relationship of biphalin. The synthesis and biological activities of new analogues with modifications in positions 3 and 4A Misicka, A W Lipkowski, R Horvath, et al.
International Journal of Peptide and Protein Research|July 1, 1994
Delta opioid receptor selective ligands; DPLPE-deltorphin chimeric peptide analoguesA Misicka, A W Lipkowski, R Horvath, et al.
International Journal of Peptide and Protein Research|December 1, 1994
Delta opioid receptor selective ligands; DPLPE-deltorphin chimeric peptide analoguesA Misicka, A W Lipkowski, R Horvath, et al.
The Medical Journal of Australia|January 8, 2021
How to use imperfect tests for COVID-19 (SARS-CoV-2) to make clinical decisionsKaty Jl Bell, Fiona F Stanaway, Les M Irwig, et al.
Journal of Medicinal Chemistry|January 7, 1994
Design of cyclic deltorphins and dermenkephalins with a disulfide bridge leads to analogues with high selectivity for delta-opioid receptorsA Misicka, A W Lipkowski, R Horvath, et al.
Life Sciences|January 1, 1992
Topographical requirements for delta opioid ligands: common structural features of dermenkephalin and deltorphinA Misicka, A W Lipkowski, R Horvath, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 19, 2009
A variable neurodegenerative phenotype with polymerase gamma mutationS Stricker, H Prüss, R Horvath, et al.
Neuropathology and Applied Neurobiology|June 19, 2007
Adult-onset glycogen storage disease type 2: clinico-pathological phenotype revisitedB G H Schoser, J Müller-Höcker, R Horvath, et al.
Pageof 17

Showing results (71-80 of 164) with videos related to

Sort By:
Pageof 17
The Journal of Peptide Research : Official Journal of the American Peptide Society|July 1, 1997
Synthesis and biological properties of beta-MePhe3 analogues of deltorphin I and dermenkephalin: influence of biased chi 1 Phe3 residues on peptide recognition for delta-opioid receptorsA Misicka, S Cavagnero, R Horvath, et al.
Journal of Hypertension|April 7, 2021
ReplyKaty Bell, Jenny Doust, Kevin McGeechan, et al.
Life Sciences|January 1, 1997
Structure-activity relationship of biphalin. The synthesis and biological activities of new analogues with modifications in positions 3 and 4A Misicka, A W Lipkowski, R Horvath, et al.
International Journal of Peptide and Protein Research|July 1, 1994
Delta opioid receptor selective ligands; DPLPE-deltorphin chimeric peptide analoguesA Misicka, A W Lipkowski, R Horvath, et al.
International Journal of Peptide and Protein Research|December 1, 1994
Delta opioid receptor selective ligands; DPLPE-deltorphin chimeric peptide analoguesA Misicka, A W Lipkowski, R Horvath, et al.
The Medical Journal of Australia|January 8, 2021
How to use imperfect tests for COVID-19 (SARS-CoV-2) to make clinical decisionsKaty Jl Bell, Fiona F Stanaway, Les M Irwig, et al.
Journal of Medicinal Chemistry|January 7, 1994
Design of cyclic deltorphins and dermenkephalins with a disulfide bridge leads to analogues with high selectivity for delta-opioid receptorsA Misicka, A W Lipkowski, R Horvath, et al.
Life Sciences|January 1, 1992
Topographical requirements for delta opioid ligands: common structural features of dermenkephalin and deltorphinA Misicka, A W Lipkowski, R Horvath, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 19, 2009
A variable neurodegenerative phenotype with polymerase gamma mutationS Stricker, H Prüss, R Horvath, et al.
Neuropathology and Applied Neurobiology|June 19, 2007
Adult-onset glycogen storage disease type 2: clinico-pathological phenotype revisitedB G H Schoser, J Müller-Höcker, R Horvath, et al.
Pageof 17